Marc Brisson
Chercheur universitaire
Axe Santé des populations et pratiques optimales en santé
Dernières nouvelles
Voir toutPublications
Voir tout-
article Brisson M, Drolet M, Gingras G, Laprise JF, Chamberland É and Bruni L, Sabourin AA, Bénard É and Ndiaye C, Barnabas RV
Substantial increases in cervical cancer inequalities worldwide without enhanced human papillomavirus vaccination and screening efforts: a global modelling study
Lancet 407 (10540), 2026.
-
article Burger EA, Laprise JF, Spencer JC, Sy S, Regan MC, Drolet M, Chamberland É and Brisson M, Kim JJ
Single-dose HPV vaccination in the United States – a multi-modeling analysis
Lancet Reg Health Am 55 2026.
-
article Laprise JF, Chesson HW, Markowitz LE, Drolet M, Brisson M
Cost-Effectiveness of Extending Human Papillomavirus Vaccination to Population Subgroups Older Than 26 Years Who Are at Higher Risk for Human Papillomavirus Infection in the Unit…
Ann Intern Med 178 (11), 2025.
Projets
- Canada Research Chair in Mathematical Modeling and Health Economics of Infectious Diseases, du 2024-10-01 au 2031-09-30
- Évaluation de l’efficacité d’une et deux doses de vaccin Shingrix contre le zona, du 2025-04-01 au 2027-12-31
- Infrastructure informatique pour la modélisation mathématique et l'économie de la santé liée aux maladies infectieuses, du 2025-09-01 au 2027-07-30
- Optimizing HPV vaccination programs in Low- and Middle-Income Countries (LMIC) and Canada to reduce inequalities and reach global elimination of cervical cancer: An integrated knowledge translation dynamic-modeling approach, du 2024-10-01 au 2028-09-30
- Developing multi-virus transmission-dynamic models and mixing matrices using insights from temporal variations in infection and contact patterns before, during, and after the COVID-19 pandemic, du 2025-10-01 au 2028-09-30
- Modélisation mathématique des virus respiratoires au Québec, du 2025-04-01 au 2028-12-31
- :Examining optimal one-dose HPV vaccination programs beyond current WHO targets: An integrated knowledge translation dynamic-modeling approach, du 2025-06-01 au 2027-05-30
- Optimization of HPV vaccination and screening in Canada, considering opportunities provided by 1-dose vaccination: A mathematical modeling study, du 2023-04-01 au 2025-03-31
- Optimizing HPV vaccination programs in Low- and Middle-Income Countries (LMIC) and High-Income Countries (HIC) to reduce inequalities and reach global elimination of cervical cancer: An integrated knowledge translation dynamic-modeling, du 2024-03-01 au 2025-02-28
- Impact du biais de déplétion différentielle des susceptibles sur l'estimation de l' efficacité terrain des vaccins à partir de données populationnelles, du 2023-09-01 au 2025-12-31